GLP-1
Semaglutide
Own facility · GLP-1 Peptides
Semaglutide is a long-acting GLP-1 receptor agonist used in type 2 diabetes and chronic weight management, typically administered as a once-weekly subcutaneous injection or an oral tablet. BOOKPHARM supplies semaglutide as a pharmaceutical-grade active ingredient and supports finished-dosage manufacturing.
Supply offerings
| Business line | Business model | Regulatory status |
|---|---|---|
| FDFGLP-1 | API + FDF CMO/Supply | Approval in Iran and Laos |
| APIGLP-1 | API supply | NDC+US DMF |
Supplied for pharmaceutical manufacturing and R&D by licensed and qualified entities. Not for human use as supplied. Availability is subject to regulatory approval in the buyer's jurisdiction.